12,422 Shares in UiPath Inc. (NYSE:PATH) Bought by Mercer Global Advisors Inc. ADV

Mercer Global Advisors Inc. ADV purchased a new stake in UiPath Inc. (NYSE:PATH) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 12,422 shares of the healthcare company’s stock, valued at approximately $164,000.

Other institutional investors also recently modified their holdings of the company. ORG Partners LLC increased its holdings in UiPath by 875.6% during the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after buying an additional 1,112 shares during the last quarter. Hantz Financial Services Inc. bought a new stake in shares of UiPath in the 2nd quarter valued at about $28,000. Redwood Wealth Management Group LLC bought a new stake in shares of UiPath in the 2nd quarter valued at about $43,000. GAMMA Investing LLC lifted its stake in UiPath by 40.2% in the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock valued at $50,000 after purchasing an additional 632 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. grew its holdings in UiPath by 122.5% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 2,556 shares of the healthcare company’s stock worth $58,000 after purchasing an additional 1,407 shares during the period. 62.50% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on PATH shares. BMO Capital Markets increased their target price on UiPath from $14.00 to $15.00 and gave the stock a “market perform” rating in a research note on Friday, September 6th. Royal Bank of Canada reissued a “sector perform” rating and set a $16.00 target price on shares of UiPath in a report on Friday, September 6th. Barclays increased their price objective on shares of UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a research note on Friday, September 6th. Wells Fargo & Company boosted their target price on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Friday, September 6th. Finally, Bank of America increased their price target on UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Sixteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, UiPath currently has an average rating of “Hold” and a consensus price target of $17.71.

UiPath Price Performance

NYSE:PATH opened at $12.40 on Wednesday. UiPath Inc. has a 1 year low of $10.37 and a 1 year high of $27.87. The business has a fifty day simple moving average of $12.17 and a two-hundred day simple moving average of $15.29. The company has a market capitalization of $7.10 billion, a P/E ratio of -77.47 and a beta of 0.87.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business had revenue of $316.00 million for the quarter, compared to the consensus estimate of $303.69 million. During the same period in the prior year, the firm earned ($0.09) earnings per share. The company’s revenue was up 10.0% compared to the same quarter last year. As a group, analysts anticipate that UiPath Inc. will post -0.23 earnings per share for the current year.

Insider Activity

In related news, CFO Ashim Gupta sold 47,671 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the sale, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at $10,258,498.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 22.37% of the company’s stock.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.